News
HUNTSVILLE, Ala. -- Sleeping, eating, working; humans, as well as many other living organisms, have circadian patterns, regularly occurring, 24-hour rhythms, that are part of normal function. Dysfunctions in regular patterns – such as insomnia and unexplained fluctuations in appetite, body temperature and/or hormones — are symptoms shared by many patients with depression. Researchers at the HudsonAlpha Institute for Biotechnology, with scientists at the University of Michigan, the University of California at Irvine, Stanford University and Weill Cornell Medical College, collaborated in a study where they found the first direct evidence connecting cellular level activity in the brains of patients with depression to out-of-step circadian rhythms. These groups have been part of the Pritzker Neuropsychiatric Disorders Research Consortium for the past decade.
HUNTSVILLE, Ala. -- A group of “stealthy” individuals led by Danny Windham, chief executive officer of Digium, revealed its mutual hand last night when the Lonnie McMillian Inspiring Excellence Fund was announced at the annual HudsonAlpha Institute for Biotechnology fund raising event. “The idea of a non-profit institute for biotechnology here in Huntsville was Lonnie’s vision,” said Windham, “and proceeds from the fund will help recruit and retain the very best researchers to HudsonAlpha.” Initial gifts to the fund total $2.5 million.
HUNTSVILLE, Ala. and BURLINGTON, N.C. -- “Educational outreach at HudsonAlpha aims to deliver creative, hands-on educational experiences that raise student comprehension and build teacher confidence,” said Neil Lamb, Ph.D., director of educational outreach at the HudsonAlpha Institute for Biotechnology. The value of educational kits designed by Lamb and his staff at the HudsonAlpha Institute for Biotechnology has been acknowledged by an executed agreement with Carolina Biological Supply Company. According to Lamb, Carolina will promote and broadly distribute institute-branded, hands-on experiments and resources.
HUNTSVILLE, ALA. -- The genetic research that goes on at HudsonAlpha Institute for Biotechnology can seem complicated, the stuff of lofty science journals. A photography exhibit the institute recently commissioned, however, shows that work in a different light. It's Aidan, who recently lost his first tooth, and Brandon, who has a great sprinkle of freckles across his face. It's Sarah with her wide smile and brown eyes.
HUNTSVILLE, Ala. -- EGEN, Inc. today announced that it has recently initiated a Phase I clinical trial of its novel immunotherapy agent, EGEN-001, in combination with PEGylated liposomal Doxorubicin or Lipodox for the treatment of recurrent ovarian cancer. The EGEN-sponsored trial is conducted by a network of researchers led by Gynecologic Oncology Group (GOG) at member institutions under an agreement between the GOG and EGEN, Inc. Premal Thaker, M.D., M.S., of Washington University School of Medicine, is the Study Chair for the trial.
Nearly 130 educators from northern and central areas of Alabamaattended the February Genetic Resources Empowering Alabama Teachers workshop offered by HudsonAlpha. “Those who participated in the workshop received classroom kits with hands-on exercises in chromosomal arrangements, protein folding and the relationships between DNA, RNA and functional proteins,” said Madelene Loftin, HudsonAlpha biotechnology education specialist.
Serina Therapeutics, Inc. has developed a proprietary, patented polymer technology for drug development and announced an agreement with AstraZeneca to develop the polyoxazoline (POZ) polymer therapeutic with an AstraZeneca proprietary compound. The nature of the POZ therapeutic and the terms of the agreement were not immediately disclosed. Jeremy Schmutz receives cotton biotechnology award
News Outlet:
PR Newswire
Date published:
January 16, 2013 
NEW YORK, Jan. 17, 2013 -- As part of the recent Plant and Animal Genomic Conference held in San Diego, Calif., Dr. Don Jones of Cotton Incorporated presented the 2012 Cotton Biotechnology Award to five outstanding researchers that were instrumental in mapping the cotton genome. The diverse and talented team, composed of Dr. Andrew Paterson, Dr. Jonathan Wendel, Mr. Jeremy Schmutz, Dr. Dan Peterson and Dr. Dan Rokhsar, led the collaborative international effort to complete the first "gold standard" Gossypium genome sequence. 